U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 213026

AMONDYS 45 (CASIMERSEN)
100MG/2ML (50MG/ML)
Marketing Status: Prescription
Active Ingredient: CASIMERSEN
Proprietary Name: AMONDYS 45
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 100MG/2ML (50MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N213026
Product Number: 001
Approval Date: Feb 25, 2021
Applicant Holder Full Name: SAREPTA THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top